EKSO logo

Ekso Bionics Holdings (EKSO) Cash And Cash Equivalents

EKSO Annual Cash & Cash Equivalents

$8.64 M
-$11.89 M-57.91%

31 December 2023

EKSO Cash And Cash Equivalents Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

EKSO Quarterly Cash And Cash Equivalents

$8.29 M
+$2.41 M+40.90%

30 September 2024

EKSO Quarterly Cash And Cash Equivalents Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

EKSO Cash And Cash Equivalents Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-57.9%+40.9%
3 y3 years-32.8%-80.9%
5 y5 years+12.8%+2.9%

EKSO Cash And Cash Equivalents High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-78.6%at low-79.5%+40.9%
5 y5-year-78.6%at low-83.3%+40.9%
alltimeall time-78.6%>+9999.0%-83.3%>+9999.0%

Ekso Bionics Holdings Cash And Cash Equivalents History

DateAnnualQuarterly
Sept 2024
-
$8.29 M(+40.9%)
June 2024
-
$5.88 M(-33.1%)
Mar 2024
-
$8.80 M(+1.9%)
Dec 2023
$8.64 M(-57.9%)
$8.64 M(-13.1%)
Sept 2023
-
$9.94 M(-25.3%)
June 2023
-
$13.31 M(-18.2%)
Mar 2023
-
$16.28 M(-20.7%)
Dec 2022
$20.52 M(-49.2%)
$20.52 M(-29.7%)
Sept 2022
-
$29.18 M(-8.6%)
June 2022
-
$31.91 M(-11.8%)
Mar 2022
-
$36.18 M(-10.5%)
Dec 2021
$40.41 M(+214.2%)
$40.41 M(-7.0%)
Sept 2021
-
$43.44 M(-5.4%)
June 2021
-
$45.94 M(-7.3%)
Mar 2021
-
$49.54 M(+285.2%)
Dec 2020
$12.86 M(+18.3%)
$12.86 M(-11.6%)
Sept 2020
-
$14.55 M(+9.7%)
June 2020
-
$13.26 M(+55.7%)
Mar 2020
-
$8.52 M(-21.7%)
Dec 2019
$10.87 M(+42.0%)
$10.87 M(+34.9%)
Sept 2019
-
$8.06 M(-39.2%)
June 2019
-
$13.26 M(+43.6%)
Mar 2019
-
$9.24 M(+20.7%)
Dec 2018
$7.66 M
$7.66 M(-41.1%)
Sept 2018
-
$12.99 M(-6.4%)
June 2018
-
$13.89 M(-32.5%)
DateAnnualQuarterly
Mar 2018
-
$20.57 M(-26.0%)
Dec 2017
$27.81 M(+65.1%)
$27.81 M(-16.8%)
Sept 2017
-
$33.44 M(+212.5%)
June 2017
-
$10.70 M(+13.5%)
Mar 2017
-
$9.43 M(-44.0%)
Dec 2016
$16.85 M(-13.8%)
$16.85 M(+31.6%)
Sept 2016
-
$12.80 M(+174.6%)
June 2016
-
$4.66 M(-62.1%)
Mar 2016
-
$12.31 M(-37.0%)
Dec 2015
$19.55 M(-22.4%)
$19.55 M(+74.0%)
Sept 2015
-
$11.24 M(-30.8%)
June 2015
-
$16.25 M(-23.1%)
Mar 2015
-
$21.13 M(-16.1%)
Dec 2014
$25.19 M(>+9900.0%)
$25.19 M(+251.0%)
Sept 2014
-
$7.18 M(-34.6%)
June 2014
-
$10.97 M(-24.8%)
Mar 2014
-
$14.58 M(>+9900.0%)
Dec 2013
-
$100.00(-75.0%)
Sept 2013
-
$400.00(-78.9%)
June 2013
-
$1900.00(-93.5%)
Mar 2013
-
$29.20 K(-2.7%)
Mar 2013
$29.20 K(+247.6%)
-
Dec 2012
-
$30.00 K(+136.2%)
Sept 2012
-
$12.70 K(+144.2%)
June 2012
-
$5200.00
Mar 2012
$8400.00
-

FAQ

  • What is Ekso Bionics Holdings annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Ekso Bionics Holdings?
  • What is Ekso Bionics Holdings annual cash & cash equivalents year-on-year change?
  • What is Ekso Bionics Holdings quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Ekso Bionics Holdings?
  • What is Ekso Bionics Holdings quarterly cash and cash equivalents year-on-year change?

What is Ekso Bionics Holdings annual cash & cash equivalents?

The current annual cash & cash equivalents of EKSO is $8.64 M

What is the all time high annual cash & cash equivalents for Ekso Bionics Holdings?

Ekso Bionics Holdings all-time high annual cash & cash equivalents is $40.41 M

What is Ekso Bionics Holdings annual cash & cash equivalents year-on-year change?

Over the past year, EKSO annual cash & cash equivalents has changed by -$11.89 M (-57.91%)

What is Ekso Bionics Holdings quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of EKSO is $8.29 M

What is the all time high quarterly cash and cash equivalents for Ekso Bionics Holdings?

Ekso Bionics Holdings all-time high quarterly cash and cash equivalents is $49.54 M

What is Ekso Bionics Holdings quarterly cash and cash equivalents year-on-year change?

Over the past year, EKSO quarterly cash and cash equivalents has changed by +$2.41 M (+40.90%)